These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7422094)

  • 1. Opiate-induced muscle rigidity in the rat: effects of centrally acting agents.
    Rackham A
    Neuropharmacology; 1980 Sep; 19(9):855-9. PubMed ID: 7422094
    [No Abstract]   [Full Text] [Related]  

  • 2. Etonitazine-induced rigidity and its antagonism by centrally acting muscle relaxants.
    Barnett A; Goldstein J; Fiedler E; Taber R
    Eur J Pharmacol; 1975 Jan; 30(1):23-8. PubMed ID: 235435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement of peripheral muscle resistance in rats with chronic ischemia-induced paraplegia or morphine-induced rigidity using a semi-automated computer-controlled muscle resistance meter.
    Marsala M; Hefferan MP; Kakinohana O; Nakamura S; Marsala J; Tomori Z
    J Neurotrauma; 2005 Nov; 22(11):1348-61. PubMed ID: 16305323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of paramyon on rigidity in decerebrated animals and on tail spasm induced with morphine].
    BUTAEV BM
    Biull Eksp Biol Med; 1956 Aug; 42(8):55-7. PubMed ID: 13382936
    [No Abstract]   [Full Text] [Related]  

  • 5. Cyclobenzaprine: novel centrally acting skeletal muscle relaxant.
    Share NN; McFarlane CS
    Neuropharmacology; 1975 Sep; 14(9):675-84. PubMed ID: 1178121
    [No Abstract]   [Full Text] [Related]  

  • 6. Atipamezole, an alpha 2 antagonist, augments opiate-induced muscle rigidity in the rat.
    Weinger MB; Bednarczyk JM
    Pharmacol Biochem Behav; 1994 Nov; 49(3):523-9. PubMed ID: 7862703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histamine release by narcotics and muscle relaxants in humans.
    Moss J; Rosow CE
    Anesthesiology; 1983 Oct; 59(4):330-9. PubMed ID: 6193743
    [No Abstract]   [Full Text] [Related]  

  • 8. Role of central mu, delta-1, and kappa-1 opioid receptors in opioid-induced muscle rigidity in the rat.
    Vankova ME; Weinger MB; Chen DY; Bronson JB; Motis V; Koob GF
    Anesthesiology; 1996 Sep; 85(3):574-83. PubMed ID: 8853088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological properties of NK433, a new centrally acting muscle relaxant.
    Sakitama K; Ozawa Y; Aoto N; Nakamura K; Ishikawa M
    Eur J Pharmacol; 1995 Jan; 273(1-2):47-56. PubMed ID: 7737318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A role for CNS alpha-2 adrenergic receptors in opiate-induced muscle rigidity in the rat.
    Weinger MB; Chen DY; Lin T; Lau C; Koob GF; Smith NT
    Brain Res; 1995 Jan; 669(1):10-8. PubMed ID: 7712151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behavioral effects of morphine, levorphanol, dextrorphan and naloxone in the frog Rana pipiens.
    Pezalla PD; Stevens CW
    Pharmacol Biochem Behav; 1984 Aug; 21(2):213-7. PubMed ID: 6333037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of centrally acting muscle relaxants on the morphine-induced Straub tail reaction in mice.
    Kameyama T; Ukai M
    Chem Pharm Bull (Tokyo); 1979 May; 27(5):1063-8. PubMed ID: 498368
    [No Abstract]   [Full Text] [Related]  

  • 13. Local cerebral glucose utilization in rats with decerebrate rigidity and effects of centrally acting muscle relaxants, diazepam and tizanidine.
    Nakamura T; Ono H; Fukuda H; Tanabe M; Kozuka M; Iwata N
    Biol Pharm Bull; 1993 Jan; 16(1):33-5. PubMed ID: 8369748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new class of potent centrally acting muscle relaxants: pharmacology of oxazolidinones in rat decerebrate rigidity.
    Masaki M; Shinozaki H
    Br J Pharmacol; 1986 Sep; 89(1):219-28. PubMed ID: 2879590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversal of opioid-induced muscular rigidity in rats: evidence for alpha-2 adrenergic involvement.
    Jerussi TP; Capacchione JF; Benvenga MJ
    Pharmacol Biochem Behav; 1987 Oct; 28(2):283-9. PubMed ID: 2891145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of some antiparkinsonism drugs and centrally acting muscle relaxants on the intercollicular decerebrate rigidity in rats.
    Fukuda H; Ito T; Kokubo M
    Chem Pharm Bull (Tokyo); 1974 Dec; 22(12):2883-8. PubMed ID: 4468110
    [No Abstract]   [Full Text] [Related]  

  • 17. "Stiff-baby" syndrome: an expression of the same neural circuitry responsible for opiate-induced muscle rigidity?
    Weinger MB
    Anesthesiology; 1987 Apr; 66(4):580-1. PubMed ID: 3565835
    [No Abstract]   [Full Text] [Related]  

  • 18. The pharmacology of fletazepam a centrally-acting muscle relaxant.
    Barnett A; Goldstein J; Fiedler EP; Taber RI
    Arch Int Pharmacodyn Ther; 1974 Nov; 212(1):164-74. PubMed ID: 4476200
    [No Abstract]   [Full Text] [Related]  

  • 19. Brain sites mediating opiate-induced muscle rigidity in the rat: methylnaloxonium mapping study.
    Weinger MB; Smith NT; Blasco TA; Koob GF
    Brain Res; 1991 Mar; 544(2):181-90. PubMed ID: 2039935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological studies on 6-amino-2-fluoromethyl-3-(O-tolyl)-4(3H)-quinazolinone (afloqualone), a new centrally acting muscle relaxant. (II) Effects on the spinal reflex potential and the rigidity.
    Ochiai T; Ishida R
    Jpn J Pharmacol; 1982 Jun; 32(3):427-38. PubMed ID: 7109348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.